{"id":"NCT00943306","sponsor":"Aegerion Pharmaceuticals, Inc.","briefTitle":"Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia","officialTitle":"A Phase III, Long Term, Open Label, Follow on Study of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor 'Lomitapide' (LOMITAPIDE) in Patients With Homozygous Familial Hypercholesterolemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10-29","primaryCompletion":"2012-09-17","completion":"2014-12-01","firstPosted":"2009-07-22","resultsPosted":"2018-05-11","lastUpdate":"2018-06-13"},"enrollment":19,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Familial Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"lomitapide","otherNames":["AEGR-733","BMS-201038"]}],"arms":[{"label":"lomitapide","type":"EXPERIMENTAL"}],"summary":"This was a long term follow on study to assess the continued long term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia.","primaryOutcome":{"measure":"Percent Change in Low Density Lipoprotein Cholesterol (LDL-C)","timeFrame":"Baseline and Week 126","effectByArm":[{"arm":"Lomitapide","deltaMin":-45.5,"sd":31.35}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":10,"countries":["United States","Canada","Italy","South Africa"]},"refs":{"pmids":["17215532","36520008"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":19},"commonTop":["Diarrhoea","Nausea","Headache","Vomiting","Influenza"]}}